University of Washington clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22
What changed in the last 30 days
28 trials changed in the last 30 days: 0 stopped, 20 with notable changes, 8 with minor changes only.
- Notable: Pembrolizumab and Carboplatin · Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Results posted: Nov 20, 2026
- Notable: Vaccine (STEMVAC) for Improving Survival · Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden Recruitment opened
- Notable: Lay-Delivered Behavioral Activation in Senior Centers Primary completion date changed from estimate of Sep 30, 2025 to Jun 18, 2026
- Minor: Brentuximab Vedotin With or Without Nivolumab · Relapsed or Refractory CD30+ Lymphoma Study completion moved earlier from Jun 3, 2030 to Aug 16, 2028
- Notable: Systematic Redesign of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) Primary endpoint(s) modified
- Notable: [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression · Metastatic Breast Cancer Primary completion pushed from Dec 31, 2027 to Dec 31, 2028
- Notable: Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI Primary completion pushed from Dec 1, 2026 to Dec 1, 2028
- Minor: Lung Transplant READY CF 2: CARING CF Ancillary RCT Enrollment closed, study ongoing
- Minor: Lung Transplant READY CF 2: A Multi-site RCT Primary completion date changed from estimate of Mar 30, 2026 to Jun 22, 2026
- Notable: TRIFECTA · Neoadjuvant Intravesical Nadofaragene Firadenovec With Enfortumab Vedotin and Pembrolizumab · Muscle Invasive Bladder Cancer, TRIFECTA Trial Primary endpoint(s) modified
- Minor: ISSP · Integrated Suicide Supports and Safety Planning for Youth Primary and study completion pushed from Nov 1, 2026 to Dec 1, 2026
- Notable: VIBRANT · Virtual Implicit Bias Reduction and Neutralization Training Results posted: Nov 10, 2026
- Notable: Non-contrast DWI for Supplemental Screening Primary completion pushed from Sep 2026 to Jul 2027
- Notable: Finasteride and Cutibacterium Recruitment opened
- Notable: Resource Allocation for Alcohol Start date changed from estimate of Mar 2025 to Aug 1, 2025
- Minor: PaGeR · Parkinson's Genetic Research Study Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting
- Notable: AMANI · Accelerating Maternal and Newborn Survival: The AMANI Study Enrolling by invitation only
- Notable: VOCALE LBD · Online Peer Support for Caregivers · Lewy Body Dementia Recruitment opened
- Notable: E-Socket, Diagnostic Monitoring Primary completion pushed from Jun 30, 2029 to Jun 30, 2032
- Notable: HARNESS · Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke Primary and study completion dates pushed to Dec 31, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-19 | NCT07949760 WOKVAC Vaccine to Prevent Brain Metastases in Metastatic HER2 Positive Breast Cancer… | Phase 2 | Not Yet Recruiting |
| 2026-11-12 | NCT07930481 Non-invasive Spinal Stimulation for Gait in Genetic Spasticity | Enrolling by Invitation | |
| 2026-11-04 | NCT07915934 Adapting the "Do More, Feel Better" Intervention for Older People Living With HIV | Not Yet Recruiting | |
| 2026-11-02 | NCT07910435 Polatuzumab Vedotin, Mosunetuzumab, and Acalabrutinib for the Treatment of Mantle Cell… | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 4 | |
| Phase 1 | 5 | |
| Phase 1/2 | 7 | |
| Phase 2 | 48 | |
| Phase 2/3 | 2 | |
| Phase 3 | 6 | |
| Phase 4 | 14 |
Not charted: 183 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 48
Breast Cancer (15) · Depression (12) · Non-Hodgkin Lymphoma (11) · Heart Disease (9) · Prostate Cancer (9) · Leukemia (8) · Bladder Cancer (7) · Follicular Lymphoma (7) · Acute Myeloid Leukemia (AML) (5) · Anxiety (5)
Get alerts when University of Washington's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.